TRANSLATING BIOLOGICAL INSIGHTS INTO INNOVATIVE THERAPIES. Praxis Bioresearch is a privately held biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of a range of chronic neuropsychiatric and neurodegenerative disorders. Our lead development candidate prodrug PRX-P4-003 is designed to offer a proven therapeutic approach to multiple neuropscyhiatric indications.